Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SHANGHAI, China, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced that Chief Executive Officer, Samantha Du,...
-
SHANGHAI, China, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced that Chief Executive Officer, Samantha Du,...
-
SHANGHAI, China, Sept. 29, 2017 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, announced today that it has dosed the first patient in a...
-
NEW YORK, Sept. 22, 2017 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) announces the closing of its U.S. initial public offering of 9,583,333 American depositary shares (“ADSs”) at a price of...
-
NEW YORK, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) announces the pricing of its U.S. initial public offering of American depositary shares (“ADSs”) (the “IPO”), raising gross...
-
NEW YORK, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) announces its intent to upsize its U.S. initial public offering of American depositary shares (“ADSs”). Zai Lab now plans to...